Shandong Sinobioway Biomedicine Co., Ltd. Profile Avatar - Palmy Investing

Shandong Sinobioway Biomedicine Co., Ltd.

Shandong Sinobioway Biomedicine Co., Ltd. manufactures and supplies trimethyl orthoformate, triethyl orthoformate, trimethyl orthoacetate, phosphorous acid, ethyl formate, nerve growth factor, and alfaron in China. The company also provides NOBEX, a muri…
Chemicals - Specialty
CN, Zibo [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 14% Weak
Profitability n.A. n.A.
Fin. Growth 67% Positive
Leverage & Liquidity 17% Weak
Per Share Metrics 100% Best
Fin. Health n.A. n.A.
1 Financial Health
Metric Q1 Q3 Δ in %
Current Ratio 66.78 11.18 6.70
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -12.24 -7.61 8.67
Naive Interpretation member
2 Per Share
Metric Q1 Q3 Δ in %
Book Value 210.06 9.62 3.10
Cash 476.05 1.87 0.32
Capex 7908.31 0.01 < 0.005
Free Cash Flow 79.52 < 0.005 -0.02
Revenue 251.44 0.45 0.13
Naive Interpretation member
3 Profitability
Metric Q1 Q3 Δ in %
Gross Margin -1.32 0.79 0.80
Operating Margin 80.93 -0.06 -0.33
ROA 56.91 0.02 -0.01
ROE 56.39 0.02 -0.01
ROIC 78.26 < 0.005 -0.01
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 002581.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 002581.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 002581.SZ is permitted for members.
End of 002581.SZ's Analysis
CIK: - CUSIP: - ISIN: CNE1000012Y5 LEI: - UEI: -
Secondary Listings
002581.SZ has no secondary listings inside our databases.